Halozyme Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2021 | 146.8M |
| FY2022 | 140.6M |
| FY2023 | 134.2M |
| FY2024 | 129.4M |
| FY2025 | 123.9M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2021 | 146.8M |
| FY2022 | 140.6M |
| FY2023 | 134.2M |
| FY2024 | 129.4M |
| FY2025 | 123.9M |